Epigenetics of Prader-Willi Syndrome: A good example of translational medicine
Main Article Content
Keywords
In Situ Hybridization, Fluorescence, Karyotype, Prader-Willi Syndrome, Angelman Syndrome, 15q11-q13 Region, MS-MLPA
Abstract
In this editorial the author presents a study, concerning Prader-Willi syndrome, which is paradigmatic for translational medicine, given that it creates a synergy between genetics and molecular biology, in order to improve the care for patients suffering from this syndrome.
References
1. Rios-Flores IM, Bobadilla-Morales K, Peña-Padilla C, Corona-Rivera A, Acosta-Fernández E, Santana-Hernández J et al. Síndromes Prader-Willi y Angelman: serie de casos diagnosticados mediante la técnica de MS-MLPA. Rev Med Inst Mex Seguro Soc. 2021;59(2):170-8.
2. Prader A, Labhart A, Willi H. Ein syndrome van adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myatomieartigem zustand im nevgeborenenalter. Schweiz Med Wochenschr. 1956;86:1260-1.
3. Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic and endocrine findings. J Endocrinol Invest. 2015;38:1249-63.
4. Perez-Comas A. Angelman’s happy puppet syndrome. Bol Assoc Med PR. 1976;68:257-60.
5. Buttler MG. Imprinting disorders in humans: A review. Curr Opin Pediatr. 2020;32:719-29
6. Mendiola AJP, La Salle JM. Epigenetics in Prader-Willi syndrome. Front Genet. 2021;16:624581.
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.